MedTrace Logo

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

NCT05611307 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-07-27

No results posted yet for this study

Summary

Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant

Conditions

  • Testicular Cancer
  • Survivorship
  • ASCVD
  • Coronary Artery Disease
  • Lipid Disorder
  • Hypogonadism, Male
  • Cisplatin Adverse Reaction
  • Bone Marrow Transplant Complications

Interventions

DIAGNOSTIC_TEST

Lipid profile

Advanced lipid profile

DIAGNOSTIC_TEST

Coronary artery assessment

Coronary artery assessment via CT scans

DIAGNOSTIC_TEST

Hormone levels for hypogonadism

Hormone levels for hypogonadism

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • JDS Foundation Testis Cancer Clinical Trials Support Fund

    collaborator UNKNOWN

  • Indiana University

    lead OTHER

Principal Investigators

  • Noah Richardson, MD · Indiana University

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-11
Primary Completion
2026-12-31
Completion
2027-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05611307 on ClinicalTrials.gov